SMYD2 protein was also detected in nine of 12 (75%) HCC patient-derived tumors and all HCC cell lines (Fig. 5B), although in some of the primary tumor samples, SMYD2 appeared at a slightly higher molecular weight, the explanation of which is not known. The gene discussed is SMYD2; the disease is hepatocellular carcinoma.